Dual IKZF2 and CK1α degrader targets acute myeloid leukemia cells-Reference-Cited by-同舟云学术

Dual IKZF2 and CK1α degrader targets acute myeloid leukemia cells

Published:2023-04 Issue:4 Volume:41 Page:726-739.e11
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Park Sun-Mi,Miyamoto David K.,Han Grace Y.Q.,Chan Mandy,Curnutt Nicole M.,Tran Nathan L.,Velleca Anthony,Kim Jun Hyun,Schurer Alexandra,Chang Kathryn,Xu Wenqing,Kharas Michael G.,Woo Christina M.^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference39 articles.

1. Acute myeloid leukaemia;Estey;Lancet,2006

2. Epigenetic reprogramming in cancer;Suvà;Science,2013

3. Towards precision medicine for AML;Döhner;Nat. Rev. Clin. Oncol.,2021

4. The implications of IDH mutations for cancer development and therapy;Pirozzi;Nat. Rev. Clin. Oncol.,2021

5. IKZF2 drives leukemia stem cell self-renewal and inhibits myeloid differentiation;Park;Cell Stem Cell,2019

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure–Activity Relationship of Potent, Selective, and Orally Bioavailable Molecular Glue Degraders of CK1α;ACS Medicinal Chemistry Letters;2024-09-12

2. Novel potent molecular glue degraders against broad range of hematological cancer cell lines via multiple neosubstrates degradation;Journal of Hematology & Oncology;2024-09-02

3. Casein Kinase 1α—A Target for Prostate Cancer Therapy?;Cancers;2024-07-02

4. The emerging role of targeted protein degradation to treat and study cancer;The Journal of Pathology;2024-06-17

5. Strengthening Molecular Glues: Design Strategies for Improving Thalidomide Analogs as Cereblon Effectors and Anticancer Agents;Drug Discovery Today;2024-06